Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patientsGiuseppe Cabibbo, Calogero Cammà, Ciro Celsa et al.|Journal of Hepatology|2019Cited by 205
Personalised management of patients with hepatocellular carcinoma: a multiparametric therapeutic hierarchy conceptAlessandro Vitale, Francesco Paolo Russo, Nicoletta De Matthaeis et al.|The Lancet Oncology|2023Cited by 184
Association Between PNPLA3 rs738409 C>G Variant and Liver-Related Outcomes in Patients With Nonalcoholic Fatty Liver DiseaseStefania Grimaudo, Salvatore Petta, Rosaria Maria Pipitone et al.|Clinical Gastroenterology and Hepatology|2019Cited by 152
Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: an individual patient data meta-analysisVíctor Sapena, María Reig, Marco Enea et al.|Gut|2021Cited by 96
Diagnostic performance of endoscopic ultrasound through‐the‐needle microforceps biopsy of pancreatic cystic lesions: Systematic review with meta‐analysisMatteo Tacelli, Stefano Francesco Crinò, Ciro Celsa et al.|Digestive Endoscopy|2020Cited by 95